Federal Register Proposed rule: FDA is proposing to revise the labeling and storage requirements for certain human blood and blood components, including source plasma, by combining, simplifying, and updating specific regulations applicable to container labeling and instruction circulars, and the shipping and storage temperatures for frozen noncellular blood components. This proposed rule would facilitate the use of a labeling system using machine-readable information that would be acceptable as a replacement for the “ABC Codabar” system for labeling blood and blood components. To view this proposed rule, click here.
